Dr. Dini joined Zymeworks in May 2023, and currently serves as our Executive Director, Intellectual Property. Dr. Dini has over 20 years of experience in biotechnology and biopharma industry. Prior to joining Zymeworks, Dr. Dini was at the boutique law firm of Farber LLC, where he was involved in antibody patenting initiatives for Regeneron. Prior to that, Dr. Dini was Chief IP Counsel at Sorrento Therapeutics and Senior Patent Counsel at AbbVie, where he was involved in the patenting of Humira. Dr. Dini received his Ph.D. in Molecular Biology at SUNY Stony Brook Medical School and was a post-doctoral fellow at Stanford Medical School and Harvard Medical School, before entering law. Peter is a member of the Massachusetts Bar, a registered patent attorney with the U.S. Patent and Trademark Office and has been admitted to the U.S. Court of Appeals for the Federal Circuit and the U.S. Supreme Court.